Microsoft Word - SPDS_0918_ERP-Proposal-07-11-2018DMC

19

Associate with the National Tropical Botanical Garden and serves on AOAC working groups, stakeholders  panels and expert review panels for Foods and Dietary Supplements.  She is a member of the United  States Pharmacoepia’s (USP) Medical Cannabis Expert Panel, the Editorial Board of the Journal of AOAC  International, and she serves on the Advisory Boards of the American Botanical Council and the  American Herbal Pharmacoepia.  Holly has over 20 years experience working with natural products &  botanicals and spent many happy years conducting research on medicinal plants and giving courses at  the University of Hawaii.    ‐‐‐  Catherine Rimmer, NIST  I am the coordinator for organic analytes in dietary supplement reference materials at NIST.  ‐‐‐  Aniko Solyom  I have more than 30 years of comprehensive experience in analytical method development and  validation, using a wide variety of analytical techniques. My expertise is in development and  validation of analytical methods with particular emphasis on HPLC, LC‐MS applications and  bioactivity guided preparative separation of complex mixtures and analysis of biological samples and  dietary supplements.  In addition to HPLC technique, I have significant experience with atomic  absorption spectroscopy (AA), inductively coupled plasma emission spectroscopy (ICP), photoacoustic  spectroscopy (PA), UV‐Vis spectroscopy, elemental analysis, mass spectrometry(MS), gas  chromatography (GC), GC‐MS, LC‐MS, NMR and wet techniques.  Before founding GAAS  Corporation/GAAS Analytical, I served as director of the Analytical Core at an NIH funded Botanical  Center (Arizona Center for Phytomedicine Research). The Facility focused on quantitation and  identification of natural products and dietary supplements, particularly anti‐inflammatory compounds  from turmeric, ginger and boswellia. I developed methods to analyze these compounds from the plant  materials, extracts, commercially available dietary supplements and from different biological matrices. I  also developed and validated new assay methods according to cGLP regulations, to quantify novel  cancer drugs in plasma and urine using QQQ LC/MS technique; identifying metabolites of new cancer  drugs in plasma and urine using TOF LC/MS technique and calculating pharmacokinetic parameters.    I am an active member of AOAC International; I joined the organization in 2002. Currently, I am a  member of AOAC’s Stakeholder Panel on Dietary Supplements and member of various working  groups. I have participated in multiple AOAC organized collaborative studies (glucosamine,  ginkgo, saw palmetto) in order to validate analytical methods to be used by the dietary